Healthtech & Wellness VC Funds

Cure Ventures, based in Boston, Massachusetts, is a life sciences venture capital firm founded in 2021. The firm focuses on early-stage investments in biotechnology, particularly in new therapeutics. They aim to drive groundbreaking curative technologies from concept to clinical success. Cure Ventures closed their inaugural fund at $350 million, indicating substantial resources dedicated to their mission. The investment strategy at Cure Ventures emphasizes genetic validation to guide drug development, thus increasing the probability of success while reducing the cost of failure. They use a seed funding model to de-risk scientific ventures, with plans to co-lead Series A and B rounds for promising companies. Their hands-on approach involves embedding Cure operators within portfolio companies to assist with day-to-day decision making​. The team at Cure Ventures includes co-founders Richard Lim, David Fallace, and Lou Tartaglia, who bring extensive experience from successful biotech firms like Juno Therapeutics and Agios Therapeutics. Their backgrounds provide a strong foundation for supporting startups through scientific and operational challenges. Notable investments by Cure Ventures include Clasp Therapeutics, Kenai Therapeutics, and Tasca Therapeutics, reflecting their focus on innovative biotechnological solutions. Startups looking to approach Cure Ventures should highlight their potential for breakthrough therapies and be prepared for an intensive, collaborative partnership aimed at achieving significant medical advancements.

CV Ventures is a venture capital firm founded in 2013 with a dual base in Hong Kong and Chicago. The firm invests in life science and fintech ventures across Asia and the United States, bridging capital from Western financial markets with opportunities in the Asian technology ecosystem. Operating across the medical and biotech, fintech, education, and real estate sectors, CV Ventures targets startups and more mature businesses across North America and Asia-Pacific. The fund deploys checks of $250,000 to $5 million at seed and Series A stages, led by a two-partner team based in the United States. Portfolio companies include Gini, a fintech platform, and the Model UN Development Organization in the education sector, reflecting the fund's range across technology and mission-driven businesses. With 5 investments across healthtech, fintech, education, and related categories, CV Ventures has operated as a highly selective vehicle focused on cross-border opportunities that benefit from the firm's Hong Kong-Chicago network. CV Ventures occupies a niche defined by its geographic bridge between Asian and North American markets — a position that requires genuine operational credibility in both regions. The fund's current status is listed as inactive, though its portfolio represents a selective body of work across the life sciences and fintech sectors that sit at the intersection of the firm's two home markets.

CyberAgent Capital (CAC) is a prominent venture capital firm specializing in early-stage investments, particularly in internet and technology-based startups. Founded in 2006 as part of the larger CyberAgent Group, the firm focuses on companies in the seed and early-growth stages. With a strong global network, CAC operates across key markets in Asia, including Japan, China, Taiwan, Indonesia, Vietnam, and Thailand, offering startups a bridge to regional and global expansion. The firm’s investment philosophy centers on incubating and accelerating internet-based businesses. CAC provides deep strategic and operational support, particularly in user acquisition, UI/UX design, and marketing strategies. This hands-on approach allows startups to leverage CAC’s extensive industry knowledge and its connection to the CyberAgent Group, fostering quicker growth in fast-moving markets​. CyberAgent Capital typically invests in startups aiming for global reach and scalability, helping them expand across borders. The firm manages several funds and offers flexible investment sizes depending on the growth stage, supporting companies from the initial idea phase to market expansion​. Some of CAC’s notable portfolio companies include Tokopedia, Coda Payments, and Viddsee, which highlight the firm’s successful track record in backing high-potential tech-driven ventures​.

CyberGuild Ventures is a Jerusalem-based venture building studio and early-stage venture capital fund founded in 2018, with a sharp focus on the cybersecurity sector and a deep foothold in Israel's global cybersecurity ecosystem. The firm positions itself as a power multiplier for investors — combining venture studio operational capabilities with early-stage VC investing to accelerate pre-seed and seed-stage cybersecurity startups from formation through initial market traction. CyberGuild invests and leads rounds at pre-seed through Series A stages, writing checks of $100,000 to $1 million across cybersecurity, big data, IoT, digital health, and enterprise IT. The firm's leadership team includes a Managing Partner with M&A experience and a CTO formerly at Intel, grounding its technical assessments in hands-on engineering and corporate technology development backgrounds. The firm is listed on Israel's Startup Nation Finder and IVC Data, reflecting its recognized standing within Israel's startup community. Portfolio includes Intelici in network management software. CyberGuild operates at a very early stage where technical credibility and access to Israel's elite security talent networks are primary value drivers. The firm's venture studio model means it can support portfolio companies with operational resources — including product strategy, technical architecture, and business development — in addition to the capital required to move from idea to initial product. The Jerusalem base gives it proximity to a concentration of defense and intelligence alumni who frequently found security companies.

Cycle Capital, founded in 2009 and headquartered in Montreal, Quebec, is a venture capital firm that specializes in investing in early-stage cleantech companies. The firm aims to support businesses that are developing innovative technologies to create a sustainable future. Cycle Capital manages over CAD 600 million through various funds, targeting sectors such as renewable energy, smart grid technology, energy storage, green chemicals, and advanced materials. The firm's portfolio includes a wide range of companies focused on sustainable innovations. Notable investments include Rhombus Energy Solutions, which develops bi-directional electric vehicle charging infrastructure; Bus.com, an online bus reservation platform; and Airex Energy, which transforms biomass into biochar and biocoal. Other significant investments are in GreenMantra Technologies, which converts waste plastics into specialty polymer additives, and Mysa, which creates smart thermostats for electric HVAC systems. Cycle Capital has also achieved several successful exits, including the acquisition of Rhombus Energy Solutions by BorgWarner in 2022. This acquisition was a significant milestone, showcasing the firm's ability to scale innovative companies to global markets. The firm is led by founder and managing partner Andrée-Lise Méthot, along with a team of experienced partners and venture capitalists. They emphasize long-term collaboration with entrepreneurs, providing both financial support and strategic guidance to help their portfolio companies achieve significant growth and impact.

D4V (Design for Ventures) is a Tokyo-based early-stage venture capital firm founded in 2016 by Tom Kelley, who is also a partner at IDEO, the globally renowned design consultancy. The firm manages approximately $50 million across two funds, with Fund 2 closing at JPY 5.4 billion. D4V invests at Seed and Series A stages in Japan-focused startups, with initial checks ranging from roughly $140,000 to $1.4 million and follow-on capability. The team is led by Kelley alongside partners Asumi Ota and Fumiaki Nagase. With 74 portfolio companies, D4V has achieved four IPO exits. Notable holdings include ExaWizards (AI, IPO), AirCloset (AI fashion styling, IPO), THECOO (IPO), Ubie (AI healthcare), Cinnamon AI (enterprise AI), CrowdLoan (fintech), and SUN METALON (deep tech). The portfolio spans AI, healthcare, fintech, industrial digitization, entertainment, and e-commerce. D4V's defining feature is its formal integration of IDEO's design methodology into the venture process. Portfolio companies receive hands-on support in human-centered UX/UI, branding, customer experience design, and organizational structure — capabilities that go well beyond what a conventional VC offers. The firm also runs the First Designers community, providing intensive training and networking for startup designers, embedding design thinking as a competitive advantage across the entire portfolio.

DAA Capital Partners is a Geneva-based venture capital firm, established to invest in early-stage ventures across technology, consumer goods, and health sectors. Founded with a focus on sustainable growth, DAA Capital provides both financial capital and strategic support to innovative startups in Europe. The firm's investment strategy revolves around Seed and Series A funding rounds, helping young companies scale their operations and realize their potential. Some of DAA Capital’s notable investments include Creal, a company revolutionizing display technologies, Tinamu Labs, which focuses on drone automation, and Smeetz, an AI-driven marketplace platform. The firm leverages its deep industry expertise and global network to offer more than just capital, acting as a strategic partner to help its portfolio companies grow effectively. With a strong commitment to driving innovation, DAA Capital Partners continues to make impactful investments across Europe, emphasizing long-term value creation and responsible growth.

DAAL Ventures is a venture capital firm headquartered in Saudi Arabia, focusing on early-stage investments in the technology sector, particularly in emerging markets. Founded with the mission to bridge international innovation and the Middle East, DAAL plays a pivotal role in helping startups expand into the GCC region, especially Saudi Arabia. The firm is known for providing not only capital but also strategic guidance and mentorship to its portfolio companies. DAAL leverages its extensive regional network and expertise to support startups in various sectors, including fintech, SaaS, artificial intelligence (AI), Internet of Things (IoT), and big data. DAAL Ventures stands out for its collaborative approach, positioning itself as a partner to the companies it backs. This involves helping entrepreneurs scale their operations globally and connecting them with world-class investors and local partners in the Middle East. The firm has invested in a diverse range of startups, including Pulppo, a Mexican proptech platform, and Paym.es, a fintech company, highlighting its commitment to identifying high-potential tech ventures across different regions​. The firm’s vision is to be a leader in tech-focused venture capital in Saudi Arabia and the broader GCC region. DAAL is committed to fostering growth by offering operational support, business development resources, and access to its network of strategic partners. This positions DAAL Ventures as a key player for startups looking to break into the Middle Eastern market​.

DAG Ventures is a Palo Alto-based growth-stage venture capital firm founded in 2004 by Tom Goodrich and John Cadeddu, who also co-founded Corner Ventures. One of Silicon Valley's most prolific growth investors, DAG has backed 172 companies with an exceptional track record of 130 exits and 5 unicorns. The firm focuses on later-stage investments across IT, life sciences, healthcare, consumer services, and technology, deploying $10 million to $30 million checks predominantly at Series B and C. John J. Cadeddu serves as Founder and Managing Director. DAG's portfolio is a register of consequential technology companies. Notable holdings and exits include Ambarella in semiconductors, Eventbrite in event management, FireEye in cybersecurity, Glassdoor acquired by Recruit Holdings for $1.2 billion, Grubhub in food delivery, Nextdoor in social networking, Wealthfront in robo-advisory, Wix.com in website building, Yelp in local reviews, Zettle acquired by PayPal, and Armo Biosciences in oncology. All of these companies reached IPO, acquisition, or significant secondary liquidity events. DAG's investment approach centers on identifying companies that have already demonstrated product-market fit and are ready to scale, then providing both growth capital and the firm's extensive network of corporate relationships and strategic advisors. The firm leads its positions and partners with management teams through the transition from growth-stage startup to enduring market leader — a phase that demands different skills than early-stage investing and where DAG's track record speaks for itself.

Danone Ventures, the corporate venture arm of Danone, is at the forefront of investing in groundbreaking startups within the food and beverage industry. Notable investments include Farmer's Fridge, Harmless Harvest, and Michel et Augustin, demonstrating their commitment to supporting innovative brands that push the boundaries of health and sustainability. With a strategic focus on early-stage companies, Danone Ventures targets sectors such as plant-based products, sustainable food systems, and personalized nutrition. Their geographic reach spans across North America, Europe, and increasingly into emerging markets, showcasing a global outlook with a local touch. Danone Ventures employs a proactive investment strategy, often taking significant stakes and leading funding rounds. They typically invest between $1M and $10M, providing not just capital but also leveraging Danone's extensive resources to help startups scale. The firm has shown consistent activity, with recent investments in companies like Nature’s Fynd and Ready, Set, Food!, highlighting their commitment to innovation and sustainability. The team at Danone Ventures includes experts like Laurent Marcel and Emmanuel Faber, who bring deep industry knowledge and a passion for transforming the food landscape. Startups looking to partner with Danone Ventures should emphasize their innovative approach and alignment with Danone's mission of bringing health through food to as many people as possible. Being approachable and showcasing strong market potential are key to gaining their interest. Danone Ventures is dedicated to fostering a healthier world through strategic and impactful investments.

Daphni Ventures, based in Paris, was founded in 2016 and focuses on early-stage investments with a European DNA and strong international ambition. The firm aims to support companies that contribute to making the world a better place through innovative and disruptive models, emphasizing social and environmental sustainability. Daphni's investment thesis revolves around empowering founders to create a sustainable future by leveraging deep tech and innovation. The firm has made over 80 investments and has seen multiple successful exits, including Shine.fr, Masteos, and Foxintelligence. Their portfolio includes a wide range of companies such as ZOE, a personalized nutrition platform; Double, a remote executive assistant service; and Masteos, a full-stack real estate agency. They also back companies in sectors like edtech, fintech, and health tech, supporting ventures that focus on the circular economy, upcycling, social inclusion, and the future of work. Daphni operates three main investment vehicles: Purple, Yellow, and Dastore, each focusing on different areas of innovation and sustainability. Their approach involves not only providing capital but also offering operational support and access to a community of experts to facilitate collaboration and knowledge-sharing among their portfolio companies.

Dark Horse Ventures is an early-stage venture capital firm founded in 2019 by Bradley Griggs, headquartered in Danville, California with active operations in Mexico City. The firm focuses on high-impact startups across Mexico and Latin America, targeting sectors including fintech, health, real estate, data analytics, and basic services — areas where technology adoption is accelerating rapidly and where solving fundamental problems can generate outsized returns. Griggs leverages cross-border expertise to bridge US capital with Mexico City and Latin American startup opportunities. Dark Horse leads rounds at pre-seed and seed stages, writing checks of $500,000 to $1 million. Portfolio companies include Tu Identidad, an identity verification platform in which Dark Horse led a $600,000 seed round alongside Finnovista; Solili, a real estate data platform; Moons, a healthcare and dental services company; Homie, a real estate services marketplace; and UnDosTres, a digital payments platform. The most recent investment was Nave Analytics' pre-seed round in March 2024. With 9 investments and a team of 5 including 2 partners, the fund operates with close founder engagement. Dark Horse Ventures positions itself as a specialist in Mexico and Latin America's emerging digital economy, backing companies that solve fundamental challenges for consumers and businesses across the region. The firm's bi-national presence and Griggs' network across the US and Mexico enable it to support founders on both sides of the border as they scale.

Darling Ventures is an early-stage venture capital firm based in San Francisco, focusing on providing seed funding to startups with disruptive potential. The firm invests primarily in pre-seed and seed rounds, with check sizes ranging from $50,000 to $250,000. Darling Ventures has built a reputation for backing innovative technology companies, especially in sectors such as digital health, AI, SaaS, fintech, and cloud infrastructure. Their hands-on approach to investing involves closely supporting portfolio companies with growth strategies, market expansion, and preparing for subsequent funding rounds. The firm's portfolio includes startups like Everlywell, Hummingbird, and Berbix, showcasing their commitment to scaling tech-driven solutions in industries with significant growth potential. With a global focus, Darling Ventures leverages its network and expertise to guide founders toward successful outcomes, ensuring they are well-positioned for the next stages of their journey. Founded by Daniel Darling, the firm prides itself on identifying early-stage opportunities in high-growth sectors and helping companies reach product-market fit quickly. Darling Ventures often works as a lead investor but also collaborates with other VCs to maximize the chances of success for the companies in its portfolio. Their strong involvement in their investments sets them apart, offering more than just capital to founders—they bring strategic advice, mentorship, and connections to the table.

DART Labs & Ventures is a Zurich-based early-stage venture capital firm founded in 2017 by Sophie Lamparter and Arijana Walcott, both serving as Managing Partners, with a satellite office at swissnex San Francisco. The firm invests in European academics, innovators, and early-stage entrepreneurs working on breakthrough technologies for health and climate impact, with a notable 50% diversity factor across its portfolio. DART provides each portfolio company with a tailored 12-month acceleration program designed specifically to help European startups navigate and expand into the US market. DART leads rounds and deploys $200,000 to $300,000 at pre-seed and seed stages. The health portfolio includes Bea Fertility in at-home fertility care, BottNeuro in digital brain health, Impli in implantable bio-sensors, Perivision in AI-powered vision care, Resmonics in remote lung monitoring, Una Health in blood sugar tracking, and Xsensio in on-skin bio-sensors. The climate portfolio spans Fluidsolids in bioplastics, Gaeastar in sustainable cups, Inergio in mini fuel cells, and Orbillion Bio in cultivated meat. Across 15 investments, the firm has recorded 1 exit (VAY, September 2021). A 30-plus-member advisory network spanning Google, Meta, Stanford, ETH Zurich, Daimler, Takeda, and True Ventures provides portfolio companies with access to corporate partners, academic institutions, and top-tier investors. Venture Partner Priska Roesli leads the firm's finance function. DART also operates Vitamin°C, a female-led initiative focused on climate change mitigation.

Darwin Ventures is a San Francisco-based venture capital fund of funds specializing in providing access to early-stage U.S. venture capital funds, primarily focused on technology, IT, and healthcare. Established to offer selective investments in top-tier VC funds, Darwin leverages diversification across industries to minimize risk while maximizing returns. Their portfolio spans over 100 investments, including partnerships with prominent early-stage VCs. Darwin’s strategy emphasizes investing in multiple funds, reducing the exposure to any single investment. This approach allows investors, particularly institutional and high-net-worth individuals, to benefit from the growth of early-stage startups without bearing the risk associated with direct investments in one company or fund. The firm has successfully raised and deployed five fund-of-funds and manages investments across Series A and B stages. Led by an experienced team with a strong presence in Silicon Valley and the United States, Darwin focuses on long-term forces that shape industries, ensuring their investments align with the technological shifts driving the future economy. They are known for their disciplined and diversified approach, particularly in sectors like health tech and digital infrastructure. The firm’s leadership includes veterans from the venture capital and technology industries, ensuring they are well-positioned to support the success of their partner funds and portfolio companies.

DataPower Ventures (DPV) is a New York City-based venture capital firm founded in 2021 by David Yakobovitch, a former Google Product Lead and AI Policy Ambassador. Operating as a bi-coastal fund bridging New York City and Silicon Valley innovation ecosystems, DPV employs a distinctive barbell strategy: combining early-stage investments in transformative AI companies with selective growth-stage positions in category-defining leaders. The firm is registered with the SEC as an investment adviser and also operates a syndicate on AngelList. DPV writes checks of $100,000 to $250,000, concentrating on exceptional technical founders building at the intersection of applied AI, inference, deep technology, and data-driven platforms across enterprise software, healthcare, financial services, and sustainability. With approximately 52 investments and 26 portfolio companies, the firm has backed some of the most consequential AI companies of the current cycle, including OpenAI, Anthropic, Databricks, SSI, Eleven Labs, Harvey, Perplexity AI, Hammerspace, Together AI, Apptronik, and Revelio Labs. Yakobovitch hosts the HumAIn Podcast on AI and data science, extending DPV's presence into the AI research and practitioner community. Christina Ellwood serves as Board Member and CMO. The fund's primary US focus is complemented by investments in Canada, Israel, and the United Kingdom. DPV's thesis is that the most important AI infrastructure and application companies of the next decade are being built now, and that backing the strongest technical founders at the earliest stages creates the most durable portfolio positions.

BES Management DAC, in partnership with Davy and BDO, manages the Employment and Investment Incentive Scheme (EIIS) fund, a leading source of capital for Irish SMEs. The fund has a long track record, with over €200 million raised and invested in ambitious Irish businesses over the last 25 years. The EIIS provides individual investors with up to 40% tax relief for investments in qualifying companies, making it a valuable option for both tax savings and supporting local businesses. The fund is sector-agnostic, investing across various industries in all 26 counties of Ireland. Recent portfolio companies include Nutritics, Horizon Offsite, Gym+Coffee, and Connexicon Medical, illustrating its broad focus on tech, health, and consumer services. With an average investment in 6-10 companies per year, BES aligns closely with management teams to help accelerate growth, offering both financial capital and strategic support. For investors, the EIIS is particularly appealing due to the structured diversification across companies, minimizing risk while aiming for solid returns. The fund requires a minimum holding period of four years, making it a medium-term investment with potential for high rewards. Led by seasoned professionals like Ivan Murphy and Sinéad Heaney, BES Management ensures rigorous governance and a hands-on approach to nurturing the growth of Irish enterprises.

Day One Capital, founded in 2011, is a venture capital firm based in Budapest, Hungary, focusing on early-stage technology startups primarily in the Central and Eastern European (CEE) region. They are known for their investments in B2B software companies, leveraging the region's strong talent pool to support technology-driven founders. Day One Capital has built a diverse portfolio across various industries, including AI, fintech, and logistics. Notable investments include Turbine AI, which uses simulated cell technology to enhance drug discovery; Webshippy, a logistics and fulfillment service provider; and Volteum, a company aiding electric vehicle fleet management. They have also backed companies like Colossyan, which specializes in generative AI for video editing, and Commsignia, a leader in automotive IoT​. Their typical investment range is from €300k to €1.5 million for seed and Series A rounds. They have been instrumental in helping companies scale globally, providing not only capital but also strategic support and mentorship from their experienced team, which includes former government officials and seasoned investors​​. Day One Capital continues to foster growth and innovation within the CEE region, contributing significantly to the local startup ecosystem and helping companies achieve successful exits, such as AImotive's acquisition by Stellantis and NOW Technologies' acquisition by Sunrise Medical​​.

Day One Ventures, founded by Masha Bucher in 2018, is a dynamic early-stage venture capital firm based in San Francisco. Known for their unique approach, they combine investment with hands-on PR and communication support, setting them apart in the VC landscape. The fund focuses on industries such as fintech, climate and energy, AI, deep tech, consumer products, and enterprise solutions, with a geographic emphasis on North America and Europe. Their portfolio boasts notable investments in companies like DuckDuckGo, Remote, WorldCoin, and Superplastic. Day One Ventures typically invests between $100K and $1M, often leading seed and Series A rounds. They have a strong track record, with 22 exits and several unicorns under their belt, aggregating over $115 billion in value. Masha Bucher, a Forbes 30 Under 30 honoree and former PR executive, leverages her extensive communications background to provide unparalleled support to portfolio companies, from media strategy to investor introductions. The team, including key members like Drake Rehfeld and Tara Harandi-Zadeh, is deeply involved in every step of the startups' journeys, fostering a close-knit community.

DBIC Ventures, now rebranded as Furthr VC, is the venture capital arm of Furthr — formerly the Dublin Business Innovation Centre — and holds the distinction of being Ireland's first seed fund, established in 1990. With over three decades of continuous investment in early-stage Irish technology companies, the firm is one of Europe's longest-tenured seed investors. It focuses on globally scalable B2B software and Class I/II medical device companies headquartered in the Republic of Ireland, always co-investing alongside business angels, Enterprise Ireland, and other VCs. Furthr VC writes initial checks of EUR 200,000 to EUR 650,000 at seed to Series A stages, in rounds ranging from EUR 500,000 to over EUR 2 million, with significant capital reserved for follow-on investments. In 2019, DBIC Ventures and Enterprise Ireland launched a EUR 23 million Smart Tech Fund — which grew to EUR 32 million following the Furthr rebrand in 2022. With 61-plus investments across fintech, cybersecurity, healthtech, ICT, and digital transformation, the portfolio includes Klearcom in IVR testing SaaS, Evercam in construction computer vision, and Bluedrop Medical in diabetes devices. Managing Partner Richard Watson and Partner Colm O'Sullivan lead the firm, supported by Investment Associate Saurabh Kumar. Furthr's three-decade tenure in Dublin's technology ecosystem, combined with its Enterprise Ireland co-investment mandate, makes it a central institutional anchor for Irish B2B software and medtech founders seeking their first institutional capital.

DBL Partners, also known as DBL Investors, is a pioneering venture capital firm that integrates financial returns with social, environmental, and economic benefits—a concept they refer to as the "Double Bottom Line." Founded in 2004 and based in San Francisco, DBL Partners has a strong portfolio that includes high-profile companies such as Tesla, SpaceX, SolarCity, and Pandora. Their investments span sectors like clean energy, sustainable products and services, information technology, and healthcare. DBL's investment strategy is rooted in the belief that strong financial performance and positive social impact are interconnected. This approach is evident in their support for companies like Revolution Foods, which provides healthy meals to schools, and Ecologic Brands, which produces environmentally friendly packaging. DBL assists its portfolio companies not only with capital but also by helping them achieve secondary social and environmental goals, such as creating jobs in underserved communities or reducing carbon footprints. Key team members include Nancy Pfund, who has been instrumental in shaping DBL's impact investment strategy. DBL's focus on nurturing the social aspects of their investments has led to successful outcomes, both in terms of market traction and community benefits. For instance, Pandora's decision to locate its headquarters in Oakland helped revitalize the area and create jobs.

DCM Ventures, founded in 1996 and based in Menlo Park, California, is a prominent venture capital firm known for its extensive portfolio and successful investments. With over $4 billion under management, DCM focuses on early-stage technology companies across the U.S., China, and Japan. Notable investments by DCM Ventures include companies like SoFi, Careem, Fortinet, and Matterport. These companies highlight DCM’s diverse investment strategy, spanning fintech, cybersecurity, consumer internet, and enterprise software. The firm has also backed companies like Bill.com and Musical.ly (now TikTok), which have seen significant growth and success​​. DCM Ventures operates with a global perspective, investing in the three largest technology markets: the U.S., China, and Japan. This strategic approach has enabled DCM to deliver strong returns to its limited partners, with a focus on early-stage SaaS, fintech startups, and consumer internet companies. The firm has seen numerous successful exits, with 254 companies in its portfolio going public or being acquired​​. The leadership team at DCM includes co-founders David Chao and Xinhe Lin, who guide the firm’s global investment strategy and operational support to its portfolio companies. For startups looking to connect with DCM Ventures, demonstrating innovative solutions in high-growth sectors such as fintech, AI, and cybersecurity can align well with the firm’s investment focus​.

DCP Capital is a leading private equity firm specializing in investments across Greater China and Asia. Founded by former senior partners of KKR and Morgan Stanley, DCP Capital brings together over 26 years of investment expertise in the region. The firm’s leadership team, including Co-Founders David Liu and Julian Wolhardt, has an impressive track record of steering successful investments through multiple economic cycles, focusing on sectors such as consumer goods, industrial technology, healthcare, financial services, and agriculture. DCP Capital raised its debut fund, DCP Capital Partners I, in 2019, closing with over $2.5 billion in commitments. This fund was significantly oversubscribed, attracting top-tier global institutional investors, including sovereign wealth funds, pension funds, and family offices. The firm employs a disciplined, value-oriented investment strategy, targeting both buyouts and significant minority stakes in companies poised for growth and industry consolidation. Their approach emphasizes operational improvements and long-term value creation, which has helped DCP build lasting partnerships with management teams across the region. DCP’s portfolio includes high-profile companies such as Ping An Insurance, Mengniu Dairy, and Adopt A Cow, a disruptive dairy company in China. The firm is known for its deep local knowledge combined with world-class investment expertise, enabling it to identify and capitalize on proprietary opportunities in the dynamic Asian market. By focusing on industries with strong growth potential and by improving operational efficiencies, DCP Capital is well-positioned to continue its success in the private equity landscape.

DCVC (Data Collective Venture Capital) is a deep tech venture capital firm based in Palo Alto, California, founded in 2010 by Matthew Ocko and Michael Driscoll. The firm focuses on investing in groundbreaking technologies that address significant global challenges across various sectors, including artificial intelligence, space, climate, engineering, and more. DCVC manages multiple funds, including DCVC V, which is a $725 million fund aimed at disrupting substantial sectors of the global economy. The firm emphasizes backing startups that employ computational and engineering approaches to solve high-stakes problems. Notable portfolio companies include Pivot Bio, Planet, Zymergen, Atomwise, Rocket Lab, and Recursion Pharmaceuticals, all of which are leaders in their respective industries. DCVC also has a specialized branch, DCVC Bio, co-founded with Dr. John Hamer and Dr. Kiersten Stead, focusing on AI-enabled life sciences platforms. This branch aims to bring new medicines to market and commercialize biological breakthroughs, with companies like AbCellera, Chroma Medicine, and Totus Medicines leading the charge​. The firm’s investment strategy is driven by a belief that venture capital can address urgent global problems profitably and equitably, turning challenges into opportunities while delivering strong returns. DCVC continues to expand its team with experts across various fields to support its growing portfolio and mission​.

De Novo Ventures was a Menlo Park, California-based venture capital firm founded in 2000 by Richard Ferrari and David Mauney, specializing exclusively in medical devices and biotechnology. The firm managed approximately $650 million across three funds, with its largest — De Novo Ventures III LP — reaching $300 million. Over its lifetime, De Novo backed more than 40 companies and led rounds throughout early and growth stages. The portfolio produced a strong exit track record: Pulmonx went public on NASDAQ at a $645 million market capitalization, EBR Systems listed on the ASX in 2021, and AxoGen completed a public offering, alongside 25 acquisitions across the portfolio. Additional companies included EndoGastric Solutions, TRIA Beauty, Benvenue Medical, and Milo. Average checks ranged from $3 million to $50 million, reflecting the capital-intensive nature of medical device development. Richard Ferrari, the managing director, brought over 35 years of medical device entrepreneurship to the partnership, having previously led CardioThoracic Systems to IPO and Cardiovascular Imaging Systems to acquisition by Boston Scientific. De Novo Ventures combined that operational depth with patient capital structured for the long regulatory cycles inherent to life sciences. The firm is now permanently closed; its most recent portfolio activity was the acquisition of TRIA Beauty by CurrentBody in October 2024.

Decent Capital, founded in 2007 by Jason Zeng, co-founder of Tencent, is a prominent venture capital firm with a global presence. The firm focuses on early-stage investments across sectors such as SaaS, consumer internet, frontier tech, and sustainable technology, with investments ranging from pre-seed to Series A stages. Decent Capital’s diverse portfolio includes notable companies like Lime, Cider, and Huizuche. Lime is well-known for its smart scooters and bikes aimed at addressing last-mile transportation issues, while Cider is a direct-to-consumer e-commerce platform for fashion. Huizuche, another significant investment, focuses on car rental services in China. The firm has seen successful exits, such as the acquisition of Oculii and Huizuche, and the IPO of FangDD on NASDAQ in 2019. The firm’s investment strategy emphasizes supporting companies through their growth stages with continued capital and strategic guidance. Decent Capital operates from multiple locations, including offices in Shenzhen, Hong Kong, Singapore, and the United States, ensuring a broad reach and impact across various markets.

Deciens Capital is a venture capital firm dedicated to supporting early-stage founders in the financial services sector. Based in San Francisco, the firm focuses on driving digital transformation in long-standing institutions. Their notable investments include Chipper Cash, a leading African fintech; Treasury Prime, a premier banking-as-a-service company; and GlacierGrid, specializing in industrial energy measurement and management solutions. Deciens Capital operates with a highly selective investment strategy, making a limited number of high-conviction investments each year, typically ranging from $500K to $10M per check. The firm's approach centers on being the first significant capital invested in companies that demonstrate increasing returns to scale and deepening competitive moats, often operating in winner-take-all markets. They prefer to be approached with clear, visionary pitches that highlight the potential for significant impact and innovation. The team is led by Daniel Kimerling, a seasoned entrepreneur and investor with a background that includes founding Standard Treasury and working at Silicon Valley Bank. He is recognized in the industry for his expertise and has been named to Forbes’ "30 under 30" and the Milken Institute’s Young Leader Circle. Deciens Capital seeks to provide more than just funding, offering comprehensive support, advice, and valuable relationships to help startups thrive from the earliest stages of their development. They emphasize a collaborative approach, working closely with founders to build the next generation of transformative financial services companies.

Deep Blue Ventures (DBV) is Italy's first deep tech venture capital fund focused on Rome, launched in 2023 and managed by Deep Ocean Capital SGR S.p.A. The fund closed its first tranche at EUR 40.8 million against a EUR 70 million target, backed by cornerstone investors including the European Investment Fund (EIF), CDP Venture Capital SGR, Blue Ocean Finance, and ReItaly21 — a coalition that reflects DBV's ambition to anchor Rome in the European deep tech map. The fund leads at seed stage, with selective Series A participation. DBV deploys EUR 500,000 to EUR 2.5 million per investment, targeting exponential technologies including artificial intelligence, quantum computing, photonics, cybersecurity, synthetic biology, and advanced materials applied to strategic sectors such as aerospace, healthcare, and sustainability. The portfolio of 7 investments — completed within the first 18 months of operation — includes AI4IV in neuromorphic computing, OhmSpace in aerospace, PhotonPath in semiconductor photonics, Genoa Instruments in super-resolution microscopy, and Random Power in quantum randomness. Key institutional partners include Leonardo, the European Space Agency, I3P incubator at Politecnico di Torino, the Italian Institute of Technology, and the National Research Council. DBV is led by Chairman and Co-Founder Emilia Garito, CEO and Co-Founder Domenico Nesci, and Chief Investment Officer Paolo Cellini. The firm operates a Deep Tech Factory Model that combines venture capital with venture building to accelerate the de-risking of breakthrough technologies from Italian and European research institutions into scalable commercial ventures.

Deep Science Ventures (DSV) is a London-based venture studio founded in 2016 that specializes in building science-driven startups across four key sectors: agriculture, computation, climate, and pharmaceuticals. DSV's approach is unique in that it combines scientific knowledge with entrepreneurial expertise to create high-impact ventures from scratch. They partner closely with founder-scientists to tackle some of the world's most pressing challenges, such as reversing global warming, developing curative therapeutics, and advancing computational technologies. DSV's portfolio includes a diverse range of companies, such as Mission Zero Technologies, which focuses on energy-efficient direct air capture of CO2, and Neobe Therapeutics, which is engineering bacteria to improve the efficacy of cancer immunotherapy. These ventures reflect DSV's commitment to creating transformative solutions that are both scientifically rigorous and commercially viable. The firm's model emphasizes de-risking ventures through deep technical and market analysis before significant capital is committed. This methodical approach ensures that the startups they create have a strong foundation for long-term success.

Deepbridge Capital, established in 2010 and headquartered in Chester, UK, focuses on providing growth capital to companies in the technology, life sciences, and renewable energy sectors. Their investment approach emphasizes supporting innovative and high-growth potential companies through various tax-efficient investment opportunities. Deepbridge Capital's portfolio includes a diverse array of companies. Notable investments are in firms like AlgaeCytes, which specializes in producing high-quality EPA oils from algae, and VoxSmart, which provides compliance management solutions for banks. They have also invested in promising startups like Thalia Design Automation, an AI-driven EDA platform, and Ibis Vision, a cloud-based vision testing software for the optical industry. The firm has made 168 investments and has seen 101 exits, showcasing their experience and success in nurturing companies to achieve significant milestones. Deepbridge Capital also supports companies through initiatives such as the Deepbridge Technology Growth EIS Fund and the Deepbridge Innovation SEIS Fund, offering financial backing and strategic guidance to early-stage businesses. The Deepbridge team, led by Managing Partner Ian Warwick, is known for their commitment to fostering innovation and growth across their investment sectors. For more information about their investments and strategic approach, you can visit their official website.

DeepWork Capital, established in 2015 and based in Orlando, Florida, is an early-stage venture capital firm. The firm primarily targets technology and life sciences startups, particularly those in U.S. regions traditionally underserved by venture capital. DeepWork Capital's investment strategy focuses on seed and Series A stage companies, often being the first institutional capital after friends, family, and angel investors. Their portfolio includes a diverse range of companies such as AbFero Pharmaceuticals, acquired by Pharmacosmos, and AireHealth, addressing respiratory challenges. Other notable investments include Astrocyte Pharmaceuticals, developing therapeutics for brain injury, and Genascence, working on gene therapy for musculoskeletal diseases. The firm also supports innovative startups like Nanophotonica, which is pioneering EL-QLED technology, and Homee, which digitizes insurance claims processes. The DeepWork Capital team, including Managing Partners Mitchel Laskey, Ben Patz, and Kathy Chiu, brings a wealth of experience from various industries. The firm emphasizes a hands-on, active engagement approach, supporting entrepreneurs before, during, and after investment. DeepWork Capital's mission is to foster innovation in regions like Florida by providing necessary capital and strategic support to tech-forward founders committed to solving significant societal challenges.

Deerfield Management, a prominent investment firm based in New York City, is dedicated to advancing healthcare through strategic investments, information, and philanthropy. With over $14.6 billion in assets under management, Deerfield maintains a diverse portfolio of more than 200 private and public investments across biotechnology, pharmaceuticals, medical devices, healthcare services, and digital health industries​ . Notable portfolio companies include Graphcore, JFrog, and Netskope. The firm has a strong track record of supporting startups from early stages to mature companies, offering flexible funding models, including equity, debt, and joint ventures. Deerfield’s investment approach is characterized by deep operational support and a robust network of strategic partners and academic collaborations​ ​. Deerfield’s team comprises over 150 experienced professionals with expertise in various sectors of healthcare and finance, ensuring comprehensive support for their portfolio companies. The firm’s initiatives, such as the Deerfield Discovery and Development (3DC) and the Cure Campus, further highlight their commitment to fostering innovation and addressing complex health issues​​. The Deerfield Foundation, part of the firm’s philanthropic efforts, focuses on improving healthcare delivery, particularly for underserved populations, and has invested over $68 million in various health initiatives.

Define Ventures is a premier early-stage venture capital firm, singularly focused on investing in digital health companies. With a keen eye for transformative potential, Define Ventures partners with innovative entrepreneurs to reshape the healthcare landscape. Their portfolio features notable investments such as Blackbird Health, which is revolutionizing pediatric mental health, and Lightship, a pioneer in decentralized clinical trials. Define Ventures operates primarily within the digital health sector, focusing on business models that integrate technology and healthcare to create scalable solutions. Geographically, they concentrate their efforts within the United States, fostering close relationships with startups that promise substantial impact in the national healthcare system. The firm’s strategy centers on leading early-stage funding rounds, including incubation, seed, Series A, and Series B stages. Define Ventures is renowned for their hands-on approach, providing not just capital but also strategic guidance and industry expertise to help their portfolio companies thrive. The team is led by industry veterans like Lynne Chou O'Keefe, the founder and managing partner, whose vision drives the firm's success. Other key members include A.G. Breitenstein and Frank Williams, both of whom bring extensive experience in healthcare and digital innovation. Define Ventures has recently closed $460 million across Fund III and an Opportunities Fund, cementing its position as a significant player in digital health investment.

Defy Ventures, a New York-based venture capital firm founded in 2010 by Catherine Hoke, focuses on early-stage investments and supporting entrepreneurs, particularly those with unconventional backgrounds such as former convicts. The firm is dedicated to fostering entrepreneurship, employment, and character training for its community. Defy's portfolio includes notable companies such as Nautilus Biotechnology, Empower, and Shujinko. They have made significant investments in various sectors, including high tech, business services, and food and agriculture tech. Recent investments include Monitaur, Writ, and Delivery Collective. The firm values authenticity and the tenacity needed to transform bold ideas into lasting companies. Defy Ventures aims to be the partner of choice for today's daring startup founders, helping them become tomorrow's visionary leaders. They emphasize working behind the scenes to amplify the success of their portfolio companies.

Delight Ventures is a Tokyo-based venture capital firm founded in July 2019 by Tomoko Namba, founder and chairperson of DeNA, one of Japan's leading internet companies. Originally spun out as a corporate venture unit with DeNA as its sole limited partner, the firm operates independently with investment decisions made by an autonomous team. Delight manages two funds — Fund I at approximately $100 million and Fund II at JPY 15 billion raised in 2023 — and has built a portfolio of 83 investments across Japan. The firm invests at pre-seed, seed, and Series A stages with average checks around $2 million and leads rounds. Focus sectors span AI, software, fintech, health tech, biotech, and climate tech. Portfolio companies include Matilda, Woodstock, EMLink, FundingBee, and A-SEEDS. Beyond direct investment, Delight operates a Venture Builder program that incubates companies from the ideation stage, often recruiting DeNA employees as founders and leveraging DeNA's business leaders as mentors — a structure unusual among Japanese VCs. A team of approximately 30, including seven partners, executes the firm's dual mandate across Japan and the United States. Managing Partners Tomoko Namba, Dai Watanabe, and Ryo Bando have structured the firm to pursue purely financial returns, ensuring portfolio companies maintain full optionality at exit with no obligation to align with a corporate parent's strategic agenda.

Delin Ventures is a UK-based, mission-driven venture capital firm that focuses on early-stage investments, specializing in two key areas: Life Sciences and the Future of Work & Learning. Established in 2015, the firm backs founders working on breakthrough technologies that can transform healthcare through cell therapies and the future of human work and learning. Delin invests in pre-seed and seed rounds, with typical ticket sizes ranging from €100,000 to €1.5 million, primarily in European startups. In the Life Sciences domain, Delin is committed to advancing cell therapy solutions that can either cure life-threatening diseases or transform them into manageable, chronic conditions. They also invest in the infrastructure necessary for the development and commercialization of these therapies. Notable investments include startups working on innovative therapeutics, medical services, and manufacturing technologies. In the Future of Work & Learning sector, Delin Ventures aims to unlock human potential by investing in technologies that shape the workforce of tomorrow. This includes HR tech, productivity tools, workforce development, and upskilling platforms. They provide hands-on support to founders, leveraging their deep operational expertise and extensive network. The team, led by founder Igor Linshits, includes experts from various industries, ensuring a strong focus on long-term impact. Delin's strategy is centered around making fewer, high-quality investments to ensure that they can offer exceptional support to their portfolio companies, which includes businesses like Fluidic Analytics, Vidsy, and Ori Biotech. The firm is highly selective, providing patient capital and working closely with founders to scale impactful solutions.

Dell Technologies Capital (DTC) is the venture capital investment arm of Dell Technologies, focusing on early-stage investments in the enterprise technology space. Since its inception in 2012, DTC has invested in over 150 companies, helping to propel innovations in data and analytics, cybersecurity, infrastructure, developer tools, and silicon. Their notable portfolio includes industry leaders like DocuSign, MongoDB, and Cylance​. DTC’s investment strategy is to partner with founders from the early stages and provide not only capital but also deep domain expertise and operational support. The firm’s extensive network within Dell Technologies offers startups real customer connections and the opportunity to scale with the backing of a tech giant. Investments typically range from seed to growth stages, with DTC often leading the rounds​. Headquartered in Palo Alto, California, DTC’s team of investors, technologists, and operators work closely with portfolio companies, guiding them from inception to market leadership. This hands-on approach ensures that the startups benefit from strategic insights and operational know-how, positioning them for successful exits​​. Overall, Dell Technologies Capital stands out for its commitment to fostering groundbreaking enterprise technologies and its robust support system for startups aiming to disrupt the tech landscape.

Delphi Ventures, founded in 1988, is a venture capital firm based in San Mateo, California. The firm focuses primarily on life sciences, including biotechnology, medical devices, and healthcare IT. Over the years, Delphi Ventures has made significant contributions to the life sciences industry with over 318 investments and 190 exits. Notable investments by Delphi Ventures include Revance Therapeutics, Senseonics, and PTC Therapeutics. These companies have developed innovative solutions in neurotoxin aesthetics, continuous glucose monitoring, and treatments for rare diseases, respectively. Revance Therapeutics, for instance, is now a public company with significant revenue, reflecting Delphi Ventures' ability to identify and nurture high-potential startups. Delphi Ventures' investment strategy is centered on early and growth-stage investments, with a focus on supporting pioneering technologies and therapies. The firm has a strong track record of successful exits, including companies that have gone public such as EBR Systems and Senseonics, as well as several notable acquisitions like Seattle Genetics and Acclarent. The team at Delphi Ventures is led by experienced professionals such as Deepa Pakianathan, Douglas Roeder, and founder James Bochnowski. Their expertise and deep industry knowledge play a critical role in guiding portfolio companies toward successful growth and market leadership.

Delta Partners is a Dublin-based venture capital firm specializing in early-stage investments in technology companies. Founded in 1994, the firm has a strong track record with over 140 investments and €1.8 billion in exit returns. Delta Partners focuses on seed and Series A investments, supporting companies from their foundation stage through to successful scaling and exits. They emphasize building solid company foundations and capital-optimizing cultures to increase the likelihood of success. The Delta team includes experienced partners like Dermot Berkery, Maurice Roche, Amy Neale (formerly of Mastercard), and Richard Barnwell (founder of Digit Games). They are committed to integrating sustainability risks into their investment process, ensuring that environmental, social, and governance (ESG) factors are considered throughout the lifecycle of their investments. Delta Partners operates with a partner-led approach, providing startups with direct access to senior-level experience from the first conversation. This hands-on support helps entrepreneurs navigate their journey from seed to Series A and beyond.

Demeter, a major European player in venture capital, private equity, and infrastructure, focuses on investments that drive the energy and ecological transition. Founded in 2005, Demeter manages €1.3 billion across its funds and has completed over 230 investments. The firm targets innovative startups, SMEs, and infrastructure projects, offering investments ranging from €1 million to €30 million. Notable investments include McPhy Energy, which specializes in hydrogen production, storage, and distribution technologies, and Ynsect, which produces environmentally friendly insect-based products. Demeter also supports companies like Sunna Design, which develops solar LED lighting solutions, and Sweetch Energy, a renewable energy firm focusing on osmotic energy. One of Demeter's significant initiatives is the recent launch of a €500 million fund in collaboration with EIT InnoEnergy. This fund aims to develop a resilient and diverse battery raw material supply chain for Europe, addressing the continent's growing demand for batteries and supporting the European Battery Alliance's goals. Demeter's investment strategy is driven by a commitment to sustainability, evident in their support for green projects like H2 Green Steel, the world's first integrated large-scale green steel plant. The firm's dedication to environmental responsibility is further reflected in their involvement in initiatives like the Climate Dividends program, which promotes sustainability across their portfolio companies.

Derayah Ventures is a Saudi-based venture capital firm that invests in early to growth-stage startups across the MENA region. Launched in 2019, the firm manages a $30 million fund focused on technology-driven businesses, particularly in sectors such as SaaS, fintech, eCommerce, artificial intelligence, Internet of Things (IoT), and marketplace platforms. Derayah primarily backs companies that are either disrupting traditional industries or organizing them through innovative solutions. The firm’s investment philosophy centers on supporting scalable startups with high growth potential and strong teams. Derayah Venture Capital provides not just financial backing but also strategic guidance to help companies expand within the MENA region, especially into Saudi Arabia. The fund focuses on post-seed, pre-Series A, and Series A stages, enabling startups to access critical capital during their early development phases. Led by a team of experienced investors, including Chairman Faris Ibrahim AlRashed, Derayah aims to build tomorrow's market leaders through a combination of capital, industry expertise, and strong local networks.

Designer Fund is a San Francisco-based venture capital firm founded by Ben Blumenrose and Enrique Allen, specializing in seed-stage investments in design-led startups. Notable investments include Omada Health, Gusto, and Stripe, companies recognized for their innovative design approaches and user-friendly interfaces. The fund primarily targets industries like financial services, healthcare, and sustainability, aiming to replace legacy systems with more efficient, user-centered solutions. Designer Fund focuses geographically on the US, with a strong presence in the Bay Area. Their strategy involves making significant contributions to seed rounds, typically around $500,000, while often not leading. They invest in about eight companies annually, allowing them to provide extensive design support through their Designer Fund Partnership. This support includes monthly design sessions, professional development workshops, and access to a community of top designers and founders. The team at Designer Fund is led by seasoned experts like Blumenrose, with extensive experience at Meta, and Allen, who has a background with Facebook’s fbFund and 500 Startups. Their collaborative approach and deep integration within the design community make them a valuable partner for startups aiming to scale their design capabilities and impact.

Detroit Venture Partners (DVP), founded in 2010 by Dan Gilbert, is a venture capital firm committed to backing early-stage tech startups that aim to drive innovation and economic growth. Based in Detroit, DVP is part of the broader Rock Family of Companies, which includes Rocket Companies, Bedrock Detroit, and the Cleveland Cavaliers. This extensive network enables DVP to offer its portfolio companies not only financial backing but also strategic partnerships and resources to help them scale effectively. DVP focuses on investing in startups that embody creativity, grit, and passion. They have a strong emphasis on companies in the technology sector, including fintech, SaaS, and logistics. Some of their notable portfolio companies include StockX, Livegistics, 100 Thieves, and CoverTree. By fostering innovation, DVP contributes to Detroit’s entrepreneurial ecosystem, helping to rejuvenate the city’s long history of industrial innovation. In addition to their investment activities, DVP runs a Summer Fellowship program that offers MBA and undergraduate students hands-on experience in venture capital and early-stage startups.

Devlabs is a micro venture capital firm with a focus on early-stage investments in North America, South America, and the Caribbean. Established in 2013 and headquartered in Oakland, California, and Temuco, Chile, Devlabs manages an $8 million fund dedicated to pre-seed investments in software startups, with plans to close a $21 million fund for agriculture and renewable energy sectors​. The firm typically invests between $100,000 and $300,000 per company in exchange for 5-15% equity, targeting industries such as B2B software in agri-business, finance, health, tourism, education, and operations​. Devlabs focuses on high-impact, high-growth tech entrepreneurs, especially those addressing multi-billion dollar problems with market-driven solutions. Devlabs was co-founded by Jose D Lopez and Ruben Hernandez, both of whom bring over 20 years of experience in venture capital, software development, and business innovation​ (devlabs)​. The firm leverages its extensive network and experience in emerging markets to reduce barriers and costs for investment, aiming to support lean, early-stage companies and help them scale rapidly.

DG Daiwa Ventures, a Tokyo-based venture capital firm founded in 2016, is a joint venture between Digital Garage and Daiwa Securities Group. The fund focuses on early-stage investments in cutting-edge technologies, such as blockchain, artificial intelligence (AI), cybersecurity, biohealth, and extended reality (xR). DG Daiwa Ventures operates globally, with a special emphasis on startups in Japan and the broader Asia-Pacific region. The firm manages two main funds: DG Lab Fund I and DG Lab Fund II, which collectively manage over 20 billion yen. These funds target high-potential tech startups by leveraging the combined expertise and incubation capabilities of both Digital Garage and Daiwa Securities. DG Daiwa Ventures has a track record of nurturing successful startups, such as Goodpatch and Akili Interactive Labs, which have gained recognition for their innovative products. DG Daiwa is known for supporting its portfolio companies with strategic resources and helping them scale through partnerships, additional fundraising, and IPO support. The firm aims to identify companies that can drive technological advancements and create substantial returns for investors through a global network of partners and later-stage investors.

DGNL Ventures is an early-stage venture capital fund founded in 2016 by Desiree Gruber and Nir Liberboim, headquartered in New York City. The firm invests exclusively in the consumer sector, making minority investments in high-growth companies across consumer technology, consumer goods, and consumer media. DGNL targets post-revenue companies with at least $1 million in sales, demonstrated product-market fit, retail distribution, and strong founding teams. Gruber also serves as CEO of Full Picture, a media and entertainment firm, giving the partnership direct industry relationships. With 27 investments to date, DGNL writes checks between $500,000 and $3 million at Seed and Series A stages. The portfolio spans food and beverage (Banza, Magic Spoon, Icelandic Provisions, Just Water), beauty and personal care (Fekkai, Moon Juice, Wander Beauty), health and wellness (Maven Clinic, Ladder, The Well), fashion (Sarah Flint), and consumer technology (Quip). Maven Clinic reached unicorn status in 2021, and the portfolio has generated nine acquisitions including Sir Kensington's and Brava Home. DGNL's investment philosophy centers on backing distinctive brands founded by differentiated operators who are disrupting traditional categories with new business models. The firm looks for founders who understand both the product and the consumer deeply, then applies its media and entertainment relationships to accelerate brand reach and retail distribution — a value-add that extends well beyond the initial check.

DHS Venture Partners is a Stockholm-based angel investment collective founded in 2015, composed of approximately 25 selected venture partners drawn from the alumni network of the Stockholm School of Economics (DHS stands for Diplomerad från Handelshögskolan i Stockholm). The partners — founders, operators, and experienced investors — invest as individuals while supporting portfolio companies as a coordinated collective backed by an extended alumni network of over 120 investments. The collective focuses almost exclusively on Swedish pre-seed and seed-stage startups, writing checks between approximately €240,000 and €700,000. With 32 investments across fintech, AI, foodtech, cleantech, healthtech, and marketplace sectors, the portfolio includes Karma (food waste marketplace), Treyd (B2B lending fintech), Lassie (pet insurance), Blykalla (small modular reactors), Airinum (air pollution protection), and Validio (big data monitoring). Three exits have been recorded, including Insurello and Qasa (rental marketplace). Key partners include tech entrepreneur Mattias Miksche, Robin Ramm-Ericson (co-founder of LeoVegas), Alexander Paterson-Pochet (founding partner at J12 Ventures), Christine Ahlstrand (founder at Climate Correction VC), and Fredrik Posse (impact investor). The collective's combined portfolio companies represent an accumulated valuation exceeding 15 billion SEK, and partners have held board seats at firms including Altor, Kinnevik, and Nasdaq-listed businesses.

DHV Digital Health Ventures is a Berlin-based, sector-focused early-stage venture capital fund founded in 2015 by Ulli Jendrik Koop, dedicated to building a sustainable digital health ecosystem across Europe. The firm is managed by DHV Management GmbH and invests in young startups pioneering human-centric healthcare solutions primarily in Germany and other European markets, with additional activity in Scandinavia, Canada, and the US. DHV leads rounds and writes checks from $250,000 to $5 million across pre-seed through Series B stages, with approximately 10 investments and two exits to date. Portfolio companies include TeleClinic (telemedicine, acquired by Zur Rose Group in 2020), Wefight (chronic illness virtual assistant, for which DHV led an $11.8 million Series A), Liva Healthcare (digital chronic disease management used by NHS England), DrugStars (medicine review and donation platform), and Movn Health. Managing Partners Ulli Jendrik Koop, Guido Hegener (an early-stage digital health investor since 2013), and Min-Sung Sean Kim (formerly at Allianz X and Samsung Catalyst Fund) lead the investment team. DHV's investment thesis prioritizes digital health startups with attractive business models that leverage technology to improve patient outcomes. The firm draws on a strong network of experienced investors, clinicians, and healthcare operators, positioning it as more than a capital source — portfolio companies gain access to clinical validation pathways and commercial partnerships that are critical for scaling health technology businesses.

DHVC, founded in 2013 by Shoucheng Zhang, is a venture capital firm based in Palo Alto, California. The firm focuses on early-stage investments across several sectors, including enterprise, consumer, fintech, and healthcare. Over the years, DHVC has built a substantial portfolio, investing in over 267 companies with 75 successful exits​. DHVC has also seen significant exits with companies like Wish Shopping, Qeexo, and Namocell, indicating their strong presence in the tech investment space. The firm’s investment strategy involves participating in a mix of seed, early-stage, and later-stage funding rounds, often co-investing with other prominent venture capital firms​. The DHVC team, led by key members such as Kevin Ding and Judy Yan, brings a wealth of experience and a global perspective to their investment approach. The firm’s operations are split between the United States and China, allowing them to leverage opportunities across major innovation hubs​.

Diagram is a venture capital firm and venture builder based in Montreal and Toronto, with over $350 million in assets under management. Launched in 2016, Diagram focuses on Fintech, Web3, and ClimateTech industries. It stands out for its hands-on approach, where it not only provides capital but also actively collaborates with founders to build and launch companies. Since its inception, Diagram has helped launch over 20 ventures, raising more than $500 million across its portfolio, and creating substantial shareholder value. The firm's investment model centers on early-stage companies, providing founders with access to its extensive global network of investors, operators, and industry leaders. This helps accelerate the growth and success of its portfolio companies. Notable investments in Diagram's portfolio include companies like WorkOS, Weights & Biases, and CitadelID. Diagram combines its venture building expertise with strategic investments, making it a strong player in supporting companies from idea to execution in their respective markets​.